Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Gastric Bypass More Effective Than Sleeves, But May Carry Hypoglycemia Risks: Study More than a quarter of gastric bypass patients suffer from low blood sugar following the procedure, research shows. April 30, 2025 Martha Garcia Add Your Comments A new study indicates roughly half of all patients who had gastric bypass weight loss surgery experienced remission of their type 2 diabetes, compared to just 20% of patients who had gastric sleeve surgery. According to findings published in the May issue of the journal The Lancet Diabetes & Endocrinology, patients who had gastric bypass surgery not only went into remission for diabetes, but they also lost more weight and were less likely to suffer from acid reflux. However, gastric bypass patients were much more likely to experience dangerously low blood sugar levels, the data reveals. Gastric bypass surgery and gastric sleeve procedures are both forms of bariatric weight loss surgeries. A gastric sleeve procedure, also known as a sleeve gastrectomy, permanently removes roughly 80% of the stomach. It reduces the size of the stomach and forces patients to eat much less in one sitting. Roux-en-Y, or gastric bypass, involves dividing the stomach and rerouting it to the lower portion of the small intestine. It effectively closes off a part of the stomach so the body will not absorb all the calories from the food eaten. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the new study, researchers from the Vestfold Hospital Trust in Tønsberg, Norway, compared gastric bypass and sleeve gastrectomy surgeries to determine if either had a better outcome on type 2 diabetes remission, weight loss and cardiovascular risk factors five years after surgery. The team, led by Dr. Jostein Wågen Hauge, conducted a single center, triple-blind randomized controlled trial at a public obesity center in Norway from October 2012 to September 2017. The study included more than 100 obese adults over 18 years old with type 2 diabetes. They were randomly assigned to laparoscopic gastric bypass or sleeve gastrectomy surgery. The findings indicate patients who had gastric bypass were more likely to experience type 2 diabetes remission, which occurred in more than 50% of gastric bypass patients, compared to only 20% of gastric sleeve patients. Patients who had gastric bypass surgery lost roughly 22% of their weight, compared to 17% weight loss for gastric sleeve patients. The procedures had similar effects on cholesterol levels, with those undergoing gastric bypass having lower LDL cholesterol at follow-up than patients who had gastric sleeve surgery. Researchers noted there was no difference between groups who experienced erosive esophagitis or Barrett’s esophagus. However, patients in the gastric sleeve group experienced pathological acid reflux more often. Conversely, patients in the gastric bypass group experienced low blood sugar more frequently after eating than the gastric sleeve group. On average 28% of patients in the gastric bypass group experienced hypoglycemia after eating, versus just 2% of patients in the gastric sleeve group. “Gastric bypass was superior to sleeve gastrectomy regarding long-term remission of type 2 diabetes, weight loss, and LDL cholesterol concentrations, at the expense of a higher frequency of symptomatic postprandial hypoglycaemia,” Hauge concluded. “These findings could inform clinical practice and future guidelines regarding the preferred surgical procedure in patients with type 2 diabetes.” Weight Loss Surgery Concerns The U.S. Food and Drug Administration (FDA) has approved nine weight loss surgeries since 1985, but only six are still available. Of those, gastric sleeve and gastric bypass are two of the most popular. Recently the FDA called for public input to discuss the benefits and risks of weight loss surgical approaches since many studies have put forth conflicting conclusions about the effectiveness and safety of the procedures. For example, two studies published in 2018 had competing outcomes. Data published by researchers from Finland concluded gastric bypass surgery is more effective than gastric sleeve to help reduce weight. However, another study published that same year which also indicated gastric bypass helped patients lose more weight, warned that gastric bypass patients often face a higher risk of adverse health complications as well. A study published by French researchers indicated both gastric bypass and gastric sleeve surgeries are linked to an increased risk of complications, nutritional disorders and even alcohol dependence. Other studies have indicated bariatric surgeries make patients more likely to commit suicide or self-harm. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Bariatric Surgery, Gastric Bypass, Gastric Sleeve, Hypoglycemia, Weight Loss, Weight Loss Surgery Written By: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. More Ozempic, Wegovy and Mounjaro Stories Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis August 15, 2025 GLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns August 6, 2025 Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators July 15, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis (Posted: today) The makers of GLP-1 drugs, Novo Nordisk and Eli Lilly, face another lawsuit claiming they failed to adequately warn consumers about the risks of gastroparesis injuries. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns (08/06/2025)Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries (07/29/2025)Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators (07/15/2025) BioZorb Marker Lawsuit Clears Hurdle To Reach Trial in January 2026 (Posted: today) A federal judge has denied a motion by Hologic to dismiss two BioZorb marker lawsuits scheduled for early bellwether trials. MORE ABOUT: BIOZORB LAWSUITNearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (08/11/2025)Failed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025) Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (Posted: yesterday) A tabletop fire pit lawsuit claims a Texas woman’s daughter was set on fire during a family gathering by an unexpected jet of flame from a Colsen fire pit that was later recalled due to burn injury risks. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAlcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025)
Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis (Posted: today) The makers of GLP-1 drugs, Novo Nordisk and Eli Lilly, face another lawsuit claiming they failed to adequately warn consumers about the risks of gastroparesis injuries. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns (08/06/2025)Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries (07/29/2025)Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators (07/15/2025)
BioZorb Marker Lawsuit Clears Hurdle To Reach Trial in January 2026 (Posted: today) A federal judge has denied a motion by Hologic to dismiss two BioZorb marker lawsuits scheduled for early bellwether trials. MORE ABOUT: BIOZORB LAWSUITNearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (08/11/2025)Failed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)
Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (Posted: yesterday) A tabletop fire pit lawsuit claims a Texas woman’s daughter was set on fire during a family gathering by an unexpected jet of flame from a Colsen fire pit that was later recalled due to burn injury risks. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAlcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025)